• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Immunomedics Inc. (IMMU)

    -NasdaqGM
    4.12 Down 0.01(0.24%) 4:00PM EDT
    |After Hours : 4.12 Down 0.00 (0.01%) 4:22PM EDT
    Add to Portfolio
    Prev Close:4.13
    Open:4.10
    Bid:4.12 x 1200
    Ask:4.22 x 200
    1y Target Est:7.00
    Beta:-0.78
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:4.07 - 4.16
    52wk Range:3.04 - 5.48
    Volume:616,384
    Avg Vol (3m):981,521
    Market Cap:384.75M
    P/E (ttm):N/A
    EPS (ttm):-0.51
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMMU

    Comparison

    Symbol% ChgMkt Cap
    IMMUDown 0.24%384.75M
    BIIBDown 2.15%98.41B
    GSKDown 0.61%113.76B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):87.34
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-15) :-0.52
    Quarterly EPS Est (Mar-15) :-0.13
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback